Alcon Ag (ALC)

$90.75

+2.05

(+2.31%)

Market is closed - opens 7 PM, 23 May 2024

Insights on Alcon Ag

  • Decreasing Revenue

    Revenue is down for the last 2 quarters, 2.47B → 2.45B (in $), with an average decrease of 0.8% per quarter

  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, 427.0M → 248.0M (in $), with an average decrease of 41.9% per quarter

  • Vs ISRG

    In the last 1 year, Intuitive Surgical, Inc. has given 33.0% return, outperforming this stock by 17.6%

  • Vs ISRG

    In the last 3 years, Intuitive Surgical, Inc. has given 45.8% return, outperforming this stock by 13.7%

Performance

  • $90.10
    $90.87
    $90.75
    downward going graph

    0.72%

    Downside

    Day's Volatility :0.85%

    Upside

    0.13%

    downward going graph
  • $69.21
    $90.90
    $90.75
    downward going graph

    23.74%

    Downside

    52 Weeks Volatility :23.86%

    Upside

    0.17%

    downward going graph

Returns

PeriodAlcon AgSector (Health Care)Index (Russel 2000)
3 Months
13.35%
-0.9%
0.0%
6 Months
23.44%
12.3%
0.0%
1 Year
15.37%
12.7%
0.0%
3 Years
31.87%
17.8%
-20.1%

Highlights

Market Capitalization
43.8B
Book Value
$42.13
Dividend Share
0.285
Dividend Yield
0.3%
Earnings Per Share (EPS)
2.11
PE Ratio
42.04
PEG Ratio
4.59
Wall Street Target Price
94.34
Profit Margin
10.96%
Operating Margin TTM
15.09%
Return On Assets TTM
2.38%
Return On Equity TTM
5.15%
Revenue TTM
9.6B
Revenue Per Share TTM
19.38
Quarterly Revenue Growth YOY
4.5%
Gross Profit TTM
4.8B
EBITDA
2.2B
Diluted Eps TTM
2.11
Quarterly Earnings Growth YOY
0.43
EPS Estimate Current Year
3.07
EPS Estimate Next Year
3.52
EPS Estimate Current Quarter
0.73
EPS Estimate Next Quarter
0.75

Analyst Recommendation

Buy
    80%Buy
    9%Hold
    9%Sell
Based on 21 Wall street analysts offering stock ratings for Alcon Ag(by analysts ranked 0 to 5 stars)
Based on 21 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
17
18
16
Hold
2
2
4
Sell
2
1
1

Analyst Forecast

What analysts predicted

Upside of 3.96%

Current $90.75
Target $94.34

Company Financials

FY18Y/Y Change
Revenue
7.2B
↑ 5.32%
Net Income
-227.0M
↓ 188.67%
Net Profit Margin
-3.17%
↓ 6.94%
FY19Y/Y Change
Revenue
7.5B
↑ 4.96%
Net Income
-656.0M
↑ 188.99%
Net Profit Margin
-8.74%
↓ 5.57%
FY20Y/Y Change
Revenue
6.8B
↓ 8.99%
Net Income
-531.0M
↓ 19.05%
Net Profit Margin
-7.77%
↑ 0.97%
FY21Y/Y Change
Revenue
8.3B
↑ 21.34%
Net Income
376.0M
↓ 170.81%
Net Profit Margin
4.54%
↑ 12.31%
FY22Y/Y Change
Revenue
8.7B
↑ 5.14%
Net Income
335.0M
↓ 10.9%
Net Profit Margin
3.84%
↓ 0.7%
FY23Y/Y Change
Revenue
10.1B
↑ 15.77%
Net Income
974.0M
↑ 190.75%
Net Profit Margin
9.65%
↑ 5.81%
Q4 FY22Q/Q Change
Revenue
2.2B
↑ 1.45%
Net Income
-97.0M
↓ 183.62%
Net Profit Margin
-4.47%
↓ 9.89%
Q1 FY23Q/Q Change
Revenue
2.4B
↑ 8.34%
Net Income
174.0M
↓ 279.38%
Net Profit Margin
7.4%
↑ 11.87%
Q2 FY23Q/Q Change
Revenue
2.4B
↑ 2.98%
Net Income
169.0M
↓ 2.87%
Net Profit Margin
6.98%
↓ 0.42%
Q3 FY23Q/Q Change
Revenue
2.3B
↓ 3.84%
Net Income
204.0M
↑ 20.71%
Net Profit Margin
8.76%
↑ 1.78%
Q4 FY23Q/Q Change
Revenue
2.5B
↑ 6.42%
Net Income
427.0M
↑ 109.31%
Net Profit Margin
17.23%
↑ 8.47%
Q1 FY24Q/Q Change
Revenue
2.5B
↓ 0.79%
Net Income
248.0M
↓ 41.92%
Net Profit Margin
10.09%
↓ 7.14%
FY18Y/Y Change
Total Assets
27.1B
↓ 1.19%
Total Liabilities
4.4B
↑ 1.47%
FY19Y/Y Change
Total Assets
27.7B
↑ 2.19%
Total Liabilities
8.4B
↑ 88.83%
FY20Y/Y Change
Total Assets
27.6B
↓ 0.2%
Total Liabilities
8.8B
↑ 5.1%
FY21Y/Y Change
Total Assets
28.0B
↑ 1.45%
Total Liabilities
8.7B
↓ 0.4%
FY22Y/Y Change
Total Assets
29.2B
↑ 4.32%
Total Liabilities
9.5B
↑ 9.02%
FY23Y/Y Change
Total Assets
29.6B
↑ 1.35%
Total Liabilities
9.0B
↓ 5.72%
Q4 FY22Q/Q Change
Total Assets
29.2B
↑ 5.08%
Total Liabilities
9.5B
↑ 16.97%
Q1 FY23Q/Q Change
Total Assets
29.2B
↑ 0.07%
Total Liabilities
9.4B
↓ 1.31%
Q2 FY23Q/Q Change
Total Assets
29.2B
↓ 0.16%
Total Liabilities
9.3B
↓ 1.55%
Q3 FY23Q/Q Change
Total Assets
29.3B
↑ 0.57%
Total Liabilities
9.2B
↓ 0.55%
Q4 FY23Q/Q Change
Total Assets
29.6B
↑ 0.88%
Total Liabilities
9.0B
↓ 2.42%
Q1 FY24Q/Q Change
Total Assets
29.6B
↓ 0.13%
Total Liabilities
8.7B
↓ 2.77%
FY18Y/Y Change
Operating Cash Flow
1.1B
↓ 6.4%
Investing Cash Flow
-1.0B
↑ 47.42%
Financing Cash Flow
-78.0M
↓ 85.53%
FY19Y/Y Change
Operating Cash Flow
920.0M
↓ 19.3%
Investing Cash Flow
-1.0B
↑ 1.0%
Financing Cash Flow
659.0M
↓ 944.87%
FY20Y/Y Change
Operating Cash Flow
823.0M
↓ 10.54%
Investing Cash Flow
-572.0M
↓ 43.42%
Financing Cash Flow
466.0M
↓ 29.29%
FY21Y/Y Change
Operating Cash Flow
1.3B
↑ 63.43%
Investing Cash Flow
-1.2B
↑ 109.44%
Financing Cash Flow
-123.0M
↓ 126.39%
FY22Y/Y Change
Operating Cash Flow
1.2B
↓ 9.52%
Investing Cash Flow
-1.9B
↑ 55.68%
Financing Cash Flow
-8.0M
↓ 93.5%
Q4 FY22Q/Q Change
Operating Cash Flow
345.0M
↓ 14.18%
Investing Cash Flow
-852.0M
↑ 239.44%
Financing Cash Flow
281.0M
↓ 2441.67%
Q1 FY23Q/Q Change
Operating Cash Flow
85.9M
↓ 75.1%
Investing Cash Flow
-413.0M
↓ 51.53%
Financing Cash Flow
-21.2M
↓ 107.55%
Q2 FY23Q/Q Change
Operating Cash Flow
325.0M
↑ 278.33%
Investing Cash Flow
-413.0M
↑ 0.0%
Financing Cash Flow
-145.0M
↑ 583.22%
Q3 FY23Q/Q Change
Operating Cash Flow
501.7M
↑ 54.37%
Investing Cash Flow
-152.0M
↓ 63.2%
Financing Cash Flow
12.4M
↓ 108.58%

Technicals Summary

Sell

Neutral

Buy

Alcon Ag is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Alcon Ag
Alcon Ag
12.37%
23.44%
15.37%
31.87%
54.34%
Intuitive Surgical, Inc.
Intuitive Surgical, Inc.
6.32%
26.07%
32.99%
44.05%
153.85%
Resmed Inc.
Resmed Inc.
18.48%
41.84%
-1.92%
5.79%
93.6%
Becton, Dickinson And Company
Becton, Dickinson And Company
0.04%
-1.86%
-4.88%
-3.8%
0.19%
West Pharmaceutical Services Inc
West Pharmaceutical Services Inc
-14.33%
-5.37%
-2.49%
-1.54%
188.03%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Alcon Ag
Alcon Ag
42.04
42.04
4.59
3.07
0.05
0.02
0.0
42.13
Intuitive Surgical, Inc.
Intuitive Surgical, Inc.
72.45
72.45
7.13
6.28
0.16
0.08
NA
39.37
Resmed Inc.
Resmed Inc.
33.68
33.68
1.75
7.73
0.22
0.12
0.01
31.52
Becton, Dickinson And Company
Becton, Dickinson And Company
50.29
50.29
1.34
13.04
0.05
0.03
0.02
88.74
West Pharmaceutical Services Inc
West Pharmaceutical Services Inc
44.46
44.46
6.72
7.76
0.21
0.11
0.0
36.72
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Alcon Ag
Alcon Ag
Buy
$43.8B
54.34%
42.04
10.96%
Intuitive Surgical, Inc.
Intuitive Surgical, Inc.
Buy
$142.6B
153.85%
72.45
27.16%
Resmed Inc.
Resmed Inc.
Buy
$32.1B
93.6%
33.68
20.91%
Becton, Dickinson And Company
Becton, Dickinson And Company
Buy
$67.9B
0.19%
50.29
6.76%
West Pharmaceutical Services Inc
West Pharmaceutical Services Inc
Buy
$24.7B
188.03%
44.46
19.42%

Institutional Holdings

  • Liontrust Investment Partners LLP

    0.42%

Corporate Announcements

  • Alcon Ag Dividends September,2024

    In the quarter ending September,2024. Alcon Ag has declared dividend of $0.24

    Read More

Company Information

Alcon is an American Swiss medical company specializing in eye care products with headquarters in Geneva, Switzerland, and incorporated in Fribourg, Switzerland.

Organization
Alcon Ag
Employees
25000
CEO
Mr. F. Michael Ball
Industry
Electronic Equipment/Instruments

FAQs